For Healthcare Professionals

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis


About the study

The primary purpose of this study is to evaluate the safety and efficacy of ravulizumab for the treatment of participants with generalized myasthenia gravis (gMG).

Who can take part

You may be eligible to participate in the study if you meet the following criteria:


  1. Diagnosed with Myasthenia Gravis at least 6 months (180 days) prior to the date of the Screening Visit as confirmed by specific criteria.
  2. Myasthenia Gravis Foundation of America Clinical Classification Class II to IV at screening.
  3. MG-ADL profile must be ≥ 6 at screening and randomization (Day 1).
  4. Vaccinated against meningococcal infections within 3 years prior to, or at the time of, initiating study drug to reduce the risk of meningococcal infection (N meningitidis).


Medical Conditions

  1. Any active or untreated thymoma. History of thymic carcinoma or thymic malignancy unless deemed cured by adequate treatment with no evidence of recurrence for ≥ 5 years before screening.
  2. History of thymectomy within the 12 months prior to screening.
  3. History of N meningitidis infection.
  4. Use of the following within the time period specified below:
  5. IV immunoglobulin within 4 weeks of randomization
  6. Use of plasma exchange within 4 weeks of randomization
  7. Use of rituximab within 6 months of screening
  8. Participants who have received previous treatment with complement inhibitors (for example, eculizumab).
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.
Phone iconCall 855-752-2356Email iconEmail Study Center

Study’s details


Generalized Myasthenia Gravis




Phase 3

Participants needed


Est. Completion Date

Dec 2023

Treatment type



Alexion Pharmaceuticals identifier


Study number


Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?


Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.